Navigation Links
FRC: NIH Stem Cell Guidelines Reflect Poor Science, Ignore Real Hope for Patients
Date:4/17/2009

WASHINGTON, April 17 /PRNewswire-USNewswire/ -- Today, Family Research Council President Tony Perkins responded to the National Institutes of Health (NIH) issued draft guidance for implementing President Obama's executive order to fund embryonic stem cell research (ESCR). President Obama's decision and these guidelines will remove key limits on federal funding of ESCR. Following is Perkins' statement:

(Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO )

"The research that President Obama supports is not sound science and will destroy human life. And now the NIH draft guidelines demanded by the President will do nothing to advance stem cell research that is showing near-term benefit for suffering patients. Instead, the guidelines implement a plan that will force taxpayers to foot the bill for research that involves human embryo destruction.

"The NIH guidelines will create an incentive to cannibalize the so-called 'leftover embryos,' though they will not fund research on stem cells derived from cloning, parthenogenesis and human-animal hybrids. However, NIH clearly believes the President's executive order allows them to fund such unethical research at any point in the future. The guidelines purport to have tight informed consent requirements, but they don't even require IVF doctors and the stem cell researchers to work separately, thereby opening a gaping loophole for the researchers to increase embryo production for their research.

"Instead of funding more embryo destructive research, the government should fund research using adult stem cells that are on the cutting edge of treating patients for diabetes, spinal cord injury, heart disease, and various cancers. Unfortunately, this draft guidance only diverts limited federal resources to unethical stem cell research that has not successfully treated a single person for any disease.

"Taxpayer funding should instead focus on common ground stem cell research and support legislation like the Patient's First Act sponsored by Rep. Randy Forbes (R-VA) and Rep. Dan Lipinksi (D-IL). Congress also needs to renew the Dickey-Wicker Amendment, which would forbid taxpayer funding of the creation of human embryos solely for their destruction.

"There is great potential in this country for research and procedures that will cure many diseases and allow us to maintain our ethical standards. I urge Members of Congress to support Dickey-Wicker and focus funding on the proven science of adult stem cells."


'/>"/>
SOURCE Family Research Council
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia"
2. The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy
3. British School Kids With Diabetes Gain First Time Freedom From Injections With New Insulin Pump Guidelines
4. Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines
5. Pharmaceutical Competitive Intelligence Excellence: Optimizing Data Collection with Approved Guidelines
6. Fungitell(R) CE Marked, Referenced in IDSA and NCCN Guidelines and Added to EORTC-MSG Revised Definitions of Invasive Fungal Disease
7. American Urological Association (AUA) Clinical Guidelines Recognizes Cryotherapy as Treatment Option for Prostate Cancer Patients
8. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
9. Biopure Operations Compliant With U.K. Manufacturing Guidelines
10. Long-awaited international ethical guidelines for biobank researchers
11. Updated NIH Guidelines Offer Valuable Information on Asthma Diagnosis and Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... ... Mitotech S.A, a Luxembourg based clinical stage biotechnology company, announced positive results of ... devastating genetic disease that leads to a sudden and rapid loss of central vision. ... 11778, 14484 and 3460 mutations and having experienced the onset of symptoms more than ...
(Date:4/27/2017)... Yorba Linda, Ca (PRWEB) , ... April 27, ... ... will hear from a practicing internist, who will review how testing for 1,25-Dihydroxyvitamin ... signs that prompt ordering of 25-OH-vitamin D and 1,25 dihydroxyvitamin D. , Dr. ...
(Date:4/27/2017)... ... April 27, 2017 , ... Volunteers supported by ... engineers, and industry professionals in visiting U.S. Congressional offices in Washington, D.C., yesterday ... world photonics industry. , This year, National Photonics Initiative (NPI) Congressional ...
(Date:4/27/2017)... 27, 2017  Kinexum, a distinguished resource for research, ... the appointment of Thomas C. Seoh as ... M.D., Kinexum founder, who becomes Executive Chairman and will ... clients. Thomas Seoh commented, "I ... mission and lead the firm,s remarkable team of life ...
Breaking Biology Technology:
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and ... 2022", published by MarketsandMarkets, the market is expected to be worth USD 18.98 ... Continue Reading ... ...      ...
(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
(Date:3/22/2017)... , March 21, 2017 Vigilant ... company serving law enforcement agencies, announced today the appointment ... as director of public safety business development. ... law enforcement experience, including a focus on the aviation ... his most recent position, Mr. Sheridan served as the ...
Breaking Biology News(10 mins):